Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05951959
Title A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma (TrAVeRse)
Acronym TrAVeRse
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | CAN | AUS

Facility Status City State Zip Country Details
Research Site WITHDRAWN Duarte California 91010 United States Details
Research Site NOT_YET_RECRUITING Hollywood Florida 33021 United States Details
Research Site NOT_YET_RECRUITING Fairway Kansas 66205 United States Details
Research Site NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
Research Site NOT_YET_RECRUITING New York New York 10065 United States Details
Research Site NOT_YET_RECRUITING Stony Brook New York 11794 United States Details
Research Site RECRUITING Cleveland Ohio 44111 United States Details
Research Site RECRUITING Cleveland Ohio 44124 United States Details
Research Site RECRUITING Cleveland Ohio 44195 United States Details
Research Site NOT_YET_RECRUITING Columbus Ohio 43210 United States Details
Research Site NOT_YET_RECRUITING Philadelphia Pennsylvania 19104 United States Details
Research Site NOT_YET_RECRUITING Chattanooga Tennessee 37404 United States Details
Research Site RECRUITING Houston Texas 77030 United States Details
Research Site NOT_YET_RECRUITING Milwaukee Wisconsin 53226 United States Details
Research Site RECRUITING Heidelberg 3084 Australia Details
Research Site RECRUITING Kogarah NSW 2217 Australia Details
Research Site NOT_YET_RECRUITING Melbourne 3004 Australia Details
Research Site NOT_YET_RECRUITING Nedlands 6009 Australia Details
Research Site RECRUITING Sydney 2109 Australia Details
Research Site NOT_YET_RECRUITING Goiania 74605050 Brazil Details
Research Site NOT_YET_RECRUITING Porto Alegre 90035-003 Brazil Details
Research Site NOT_YET_RECRUITING Rio de Janeiro 22061-080 Brazil Details
Research Site NOT_YET_RECRUITING Salvador 41253-190 Brazil Details
Research Site NOT_YET_RECRUITING Sao Paulo 05652-900 Brazil Details
Research Site NOT_YET_RECRUITING São Paulo 04501-000 Brazil Details
Research Site NOT_YET_RECRUITING São Paulo 05403-010 Brazil Details
Research Site NOT_YET_RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
Research Site NOT_YET_RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Research Site NOT_YET_RECRUITING Halifax Nova Scotia B3H 2Y9 Canada Details
Research Site NOT_YET_RECRUITING Barrie Ontario L4M 6M2 Canada Details
Research Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
Research Site NOT_YET_RECRUITING Montreal Quebec H3T 1E2 Canada Details
Research Site NOT_YET_RECRUITING Montreal Quebec H4A 3J1 Canada Details
Research Site NOT_YET_RECRUITING Saskatoon Saskatchewan S7N 4H4 Canada Details
Research Site WITHDRAWN Quebec G1J 1Z4 Canada Details
Research Site NOT_YET_RECRUITING Gdynia 81-519 Poland Details
Research Site NOT_YET_RECRUITING Kraków 30-727 Poland Details
Research Site RECRUITING Warszawa 02-781 Poland Details
Research Site NOT_YET_RECRUITING Barcelona 8035 Spain Details
Research Site NOT_YET_RECRUITING Madrid 28041 Spain Details
Research Site NOT_YET_RECRUITING Santiago De Compostela (A Coruña) 15706 Spain Details
Research Site NOT_YET_RECRUITING Birmingham B9 5SS United Kingdom Details
Research Site NOT_YET_RECRUITING Gloucester GL1 3NN United Kingdom Details
Research Site NOT_YET_RECRUITING London SW3 6JJ United Kingdom Details
Research Site NOT_YET_RECRUITING London W12 0HS United Kingdom Details
Research Site RECRUITING Norwich NR4 7UY United Kingdom Details
Research Site NOT_YET_RECRUITING Nottingham NG5 1PB United Kingdom Details
Research Site RECRUITING Plymouth PL68BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field